Optimizing drug delivery to brain tumors
- 31 March 1987
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 14 (1), 1-28
- https://doi.org/10.1016/0305-7372(87)90048-x
Abstract
No abstract availableThis publication has 90 references indexed in Scilit:
- Therapeutic Efficacy of Multiagent Chemotherapy with Drug Delivery Enhancement by Blood-Brain Barrier Modification in GlioblastomaNeurosurgery, 1986
- Clinical Significance of Esterases in ManClinical Pharmacokinetics, 1985
- Neurotoxicity of chemotherapeutic agents after blood‐brain barrier modification: Neuropathological studiesAnnals of Neurology, 1983
- Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatmentCancer, 1979
- Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones IIIJournal of Pharmaceutical Sciences, 1979
- Local cerebral blood flow in the conscious rat as measured with 14C-antipyrine, 14C-iodoantipyrine and 3H-nicotine.Stroke, 1979
- THE DEVELOPMENT AND ULTRASTRUCTURE OF THE MICROVASCULATURE IN MALIGNANT GLIOMASNeuropathology and Applied Neurobiology, 1977
- The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrierJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 2Journal of Medicinal Chemistry, 1976
- The entry, accumulation and binding of diphenylhydantoin-2-C14 in brain Studies on adult, immature and hypercapnic catsInternational Journal of Neuropharmacology, 1963